Literature DB >> 7195786

Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users.

E R Gritz, V Baer-Weiss, N L Benowitz, H Van Vunakis, M E Jarvik.   

Abstract

Plasma nicotine and cotinine levels were measured in habitual users of smokeless tobacco. The subjects were 12 male college students who regularly used smokeless tobacco (11 dipped snuff and one chewed tobacco) and did not smoke cigarettes. Subjects abstained from tobacco use overnight and blood was drawn at 8 A.M. and again after a single day of ad libitum consumption of their own tobacco product. Subjects recorded the times at which tobacco was used and the remainder product was weighed. Plasma samples were analyzed by both gas-liquid chromatography (GLC) and radioimmunoassay (RIA) techniques. Subjects consumed about one third of a can of moist ground snuff (10.8 gm) in eight dips spaced throughout the day. Nicotine absorption was observed and an increase in mean plasma concentration fro 2.9 ng/ml after overnight abstinence to 21.6 ng/ml after 6 to 8 hr ad libitum consumption was recorded. Plasma cotinine concentrations rose from a morning mean of 137.3 ng/ml to an afternoon mean of 197.2 ng/ml, concentrations that are typical of those reached in regular cigarette smokers. Subjects fell into two subgroups by post hoc analysis: two-thirds absorbed substantial amounts of nicotine and one-third appeared to have almost no absorption. Subjective effects of tobacco use were not marked; there was little perception of physiologic changes, stimulation, or feelings of relaxation/satisfaction. Results are discussed in terms of pharmacologic effects, comparison of results from GLC and RIA methodologies, and implications for health behaviors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195786     DOI: 10.1038/clpt.1981.149

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  22 in total

1.  Pitfalls in the assessment of smoking status detected in a cohort of South African RA patients.

Authors:  Nimmisha Govind; Mahmood M T M Ally; Mohammed Tikly; Ronald Anderson; Bridget Hodkinson; Pieter W A Meyer
Journal:  Rheumatol Int       Date:  2016-07-08       Impact factor: 2.631

Review 2.  Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General.

Authors:  J W Cullen; W Blot; J Henningfield; G Boyd; R Mecklenburg; M M Massey
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

3.  Smokeless tobacco abstinence effects and nicotine gum dose.

Authors:  D Hatsukami; D Anton; R Keenan; A Callies
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Neonatal nicotine exposure increases excitatory synaptic transmission and attenuates nicotine-stimulated GABA release in the adult rat hippocampus.

Authors:  Joanne C Damborsky; William H Griffith; Ursula H Winzer-Serhan
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

5.  Health implications of smokeless tobacco use.

Authors: 
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

6.  Overreporting of smokeless tobacco use by adolescent males.

Authors:  S J Cohen; B P Katz; C A Drook; A G Christen; J L McDonald; B L Olson; L A Cloys; G K Stookey
Journal:  J Behav Med       Date:  1988-08

7.  Saliva cotinine and thiocyanate: chemical indicators of smokeless tobacco and cigarette use in adolescents.

Authors:  M P Noland; R J Kryscio; R S Riggs; L H Linville; L J Perritt; T C Tucker
Journal:  J Behav Med       Date:  1988-10

8.  Knowledge, intent to use, and use of smokeless tobacco among sixth grade schoolchildren in six selected U.S. sites.

Authors:  C L Backinger; B Bruerd; M B Kinney; S M Szpunar
Journal:  Public Health Rep       Date:  1993 Sep-Oct       Impact factor: 2.792

9.  Kinetics of cotinine after oral and intravenous administration to man.

Authors:  P J De Schepper; A Van Hecken; P Daenens; J M Van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players.

Authors:  D Siegel; N Benowitz; V L Ernster; D G Grady; W W Hauck
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.